Wells Fargo’s lines of credit are competitive, but it offers few small-business lending solutions ...
Company initiates legal proceedings to enforce defaulted loan and personal guaranteeFormal auction proceedings also ...
MarketBeat on MSN
Insiders Buy 3 High-Risk Stocks-Here's What's Driving the Moves
When it comes to analyzing insider trades, investors should keep several important nuances in mind. For example, insider sales can often appear alarming until one realizes that they were made under a ...
Business.com on MSN
Hidden gotchas in your business loan repayment terms
There's more to a loan than paying your monthly installment. Look for these hidden terms and fees a lender might include in a loan agreement.
Columbus McKinnon Corporation (NASDAQ:CMCO) Q3 2026 Earnings Call Transcript February 9, 2026 Columbus McKinnon Corporation beats earnings expectations. Reported EPS is $0.62, expectations were $0.61.
Advanced Energy Industries, Inc. (Nasdaq: AEIS), a global leader in highly engineered, precision power conversion, measurement, and control solutions, announced financial results for the fourth ...
Get the latest Apollo Hospitals Enterprise share price today on NSE & BSE. Explore Apollo Hospitals Enterprise stock analysis, financial performance, market capitalization, dividend history, and ...
Exelixis, Inc. (Nasdaq: EXEL) today reported financial results for the fourth quarter and fiscal year of 2025, provided an update on progress toward achieving key corporate objectives, and outlined ...
PayNearMe, a leading fintech transforming the payment experience for non-commerce businesses and their customers, today announced record results for 2025. Driven by growing demand for effective, ...
First Quantum Minerals Ltd. (“First Quantum” or the "Company”) (TSX: FM) today reports results for the three months and year-ended December 31, 2025 ...
On February 6, the United States and the Government of the Burundi signed a five-year bilateral health cooperation Memorandum of Understanding (MOU) that advances the America First Global Health ...
Capturing the immunotherapy opportunity in myeloid blood cancers In the fourth quarter of 2025, Mendus presented continued positive long-term survival data of the ADVANCE II trial in acute myeloid leu ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results